BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ — Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or “the Company”) announced today that the Court of Chancery of the State of Delaware (“the Court”) has granted the consent judgment agreed to by the Company in the case of David…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.